Free Trial

Ainos (AIMD) Competitors

Ainos logo
$1.33 -0.02 (-1.70%)
Closing price 10/5/2026 04:00 PM Eastern
Extended Trading
$1.33 0.00 (-0.30%)
As of 10/5/2026 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

AIMD vs. VTIX, FOXX, EBON, QCLS, and BOXL

Should you buy Ainos stock or one of its competitors? Ainos's main competitors and comparable companies include Virtuix (VTIX), Foxx Development (FOXX), Ebang International (EBON), Mymd Pharmaceuticals (QCLS), and Boxlight (BOXL). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "technology hardware, storage & peripherals" industry.

How does Ainos compare to Virtuix?

Virtuix (NASDAQ:VTIX) and Ainos (NASDAQ:AIMD) are both small-cap technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, earnings, risk, media sentiment and valuation.

Virtuix's return on equity of 0.00% beat Ainos' return on equity.

Company Net Margins Return on Equity Return on Assets
VirtuixN/A N/A N/A
Ainos N/A -217.50%-67.87%

Virtuix currently has a consensus price target of $11.00, suggesting a potential upside of 794.31%. Given Virtuix's stronger consensus rating and higher possible upside, equities analysts clearly believe Virtuix is more favorable than Ainos.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Virtuix
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Ainos
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Ainos has lower revenue, but higher earnings than Virtuix. Virtuix is trading at a lower price-to-earnings ratio than Ainos, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Virtuix$4.25M8.67-$16.80M-$0.70N/A
Ainos$120K81.80-$14.77M-$2.52N/A

In the previous week, Virtuix had 4 more articles in the media than Ainos. MarketBeat recorded 5 mentions for Virtuix and 1 mentions for Ainos. Virtuix's average media sentiment score of 0.68 beat Ainos' score of 0.14 indicating that Virtuix is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Virtuix
3 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Ainos
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Virtuix beats Ainos on 9 of the 12 factors compared between the two stocks.

How does Ainos compare to Foxx Development?

Foxx Development (NASDAQ:FOXX) and Ainos (NASDAQ:AIMD) are both small-cap technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, profitability, analyst recommendations, dividends and media sentiment.

Foxx Development has a beta of -0.34, indicating that its share price is 134% less volatile than the broader market. Comparatively, Ainos has a beta of 2.47, indicating that its share price is 147% more volatile than the broader market.

In the previous week, Foxx Development had 2 more articles in the media than Ainos. MarketBeat recorded 3 mentions for Foxx Development and 1 mentions for Ainos. Ainos' average media sentiment score of 0.14 beat Foxx Development's score of -0.04 indicating that Ainos is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Foxx Development
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Ainos
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

60.4% of Foxx Development shares are owned by institutional investors. 31.6% of Foxx Development shares are owned by company insiders. Comparatively, 9.8% of Ainos shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Ainos has lower revenue, but higher earnings than Foxx Development. Ainos is trading at a lower price-to-earnings ratio than Foxx Development, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Foxx Development$52.58M0.34-$52.69M-$7.53N/A
Ainos$120K81.80-$14.77M-$2.52N/A

Ainos has a net margin of 0.00% compared to Foxx Development's net margin of -100.20%. Foxx Development's return on equity of 0.00% beat Ainos' return on equity.

Company Net Margins Return on Equity Return on Assets
Foxx Development-100.20% N/A -74.38%
Ainos N/A -217.50%-67.87%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Foxx Development
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Ainos
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

Ainos beats Foxx Development on 7 of the 13 factors compared between the two stocks.

How does Ainos compare to Ebang International?

Ebang International (NASDAQ:EBON) and Ainos (NASDAQ:AIMD) are both small-cap technology companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, institutional ownership, profitability, media sentiment, dividends and earnings.

1.2% of Ebang International shares are owned by institutional investors. 25.4% of Ebang International shares are owned by insiders. Comparatively, 9.8% of Ainos shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Ebang International's return on equity of 0.00% beat Ainos' return on equity.

Company Net Margins Return on Equity Return on Assets
Ebang InternationalN/A N/A N/A
Ainos N/A -217.50%-67.87%

Ebang International has higher revenue and earnings than Ainos.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ebang International$6.54M2.01-$14.09MN/AN/A
Ainos$120K81.80-$14.77M-$2.52N/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ebang International
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Ainos
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Ebang International has a beta of 2.96, meaning that its stock price is 196% more volatile than the broader market. Comparatively, Ainos has a beta of 2.47, meaning that its stock price is 147% more volatile than the broader market.

In the previous week, Ebang International and Ebang International both had 1 articles in the media. Ebang International's average media sentiment score of 1.22 beat Ainos' score of 0.14 indicating that Ebang International is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Ebang International
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Ainos
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Ebang International beats Ainos on 8 of the 9 factors compared between the two stocks.

How does Ainos compare to Mymd Pharmaceuticals?

Ainos (NASDAQ:AIMD) and Mymd Pharmaceuticals (NASDAQ:QCLS) are both small-cap technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, institutional ownership, risk, earnings, analyst recommendations and media sentiment.

Mymd Pharmaceuticals' return on equity of -91.64% beat Ainos' return on equity.

Company Net Margins Return on Equity Return on Assets
AinosN/A -217.50% -67.87%
Mymd Pharmaceuticals N/A -91.64%-47.48%

9.6% of Mymd Pharmaceuticals shares are held by institutional investors. 9.8% of Ainos shares are held by insiders. Comparatively, 0.9% of Mymd Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ainos
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Mymd Pharmaceuticals
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

In the previous week, Mymd Pharmaceuticals had 1 more articles in the media than Ainos. MarketBeat recorded 2 mentions for Mymd Pharmaceuticals and 1 mentions for Ainos. Ainos' average media sentiment score of 0.14 beat Mymd Pharmaceuticals' score of 0.00 indicating that Ainos is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Ainos
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Mymd Pharmaceuticals
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Mymd Pharmaceuticals has lower revenue, but higher earnings than Ainos. Ainos is trading at a lower price-to-earnings ratio than Mymd Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ainos$120K81.80-$14.77M-$2.52N/A
Mymd PharmaceuticalsN/AN/A-$11.63M-$3.48N/A

Ainos has a beta of 2.47, meaning that its share price is 147% more volatile than the broader market. Comparatively, Mymd Pharmaceuticals has a beta of 2.32, meaning that its share price is 132% more volatile than the broader market.

Summary

Mymd Pharmaceuticals beats Ainos on 6 of the 11 factors compared between the two stocks.

How does Ainos compare to Boxlight?

Ainos (NASDAQ:AIMD) and Boxlight (NASDAQ:BOXL) are both small-cap technology companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, institutional ownership, profitability, earnings, media sentiment, dividends, risk and analyst recommendations.

6.5% of Boxlight shares are held by institutional investors. 9.8% of Ainos shares are held by company insiders. Comparatively, 15.4% of Boxlight shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ainos
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Boxlight
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Ainos has a beta of 2.47, indicating that its share price is 147% more volatile than the broader market. Comparatively, Boxlight has a beta of 0.91, indicating that its share price is 9% less volatile than the broader market.

In the previous week, Ainos and Ainos both had 1 articles in the media. Boxlight's average media sentiment score of 1.07 beat Ainos' score of 0.14 indicating that Boxlight is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Ainos
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Boxlight
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Ainos has higher earnings, but lower revenue than Boxlight. Ainos is trading at a lower price-to-earnings ratio than Boxlight, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ainos$120K81.80-$14.77M-$2.52N/A
Boxlight$104.33M0.04-$23.81M-$80.86N/A

Ainos has a net margin of 0.00% compared to Boxlight's net margin of -20.96%. Boxlight's return on equity of 0.00% beat Ainos' return on equity.

Company Net Margins Return on Equity Return on Assets
AinosN/A -217.50% -67.87%
Boxlight -20.96%N/A -23.50%

Summary

Boxlight beats Ainos on 7 of the 12 factors compared between the two stocks.

Get Ainos News Delivered to You Automatically

Sign up to receive the latest news and ratings for AIMD and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AIMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AIMD vs. The Competition

MetricAinosTechnology Hardware, Storage & Peripherals IndustryTechnology SectorNASDAQ Exchange
Market Cap$9.99M$120.64B$31.93B$13.26B
Dividend YieldN/A1.65%2.75%17.36%
P/E Ratio-0.5331.8982.0126.20
Price / Sales722.1143.93586.0295.18
Price / CashN/A22.9448.6034.70
Price / Book1.038.508.226.40
Net Income-$14.77M$3.49B$766.00M$381.07M
7 Day Performance7.26%-0.96%1.53%-0.28%
1 Month Performance-16.88%-3.46%0.35%-4.51%
1 Year Performance-65.54%52.34%167.51%1.63%

Ainos Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AIMD
Ainos
0.3174 of 5 stars
$1.33
-1.7%
N/A-62.3%$9.99M$13.60KN/A41
VTIX
Virtuix
1.991 of 5 stars
$1.20
-2.4%
$11.00
+816.7%
N/A$35.96M$4.25MN/A39
FOXX
Foxx Development
0.7375 of 5 stars
$2.58
+2.6%
N/A-43.6%$18.13M$52.58MN/A25
EBON
Ebang International
1.225 of 5 stars
$2.10
+5.8%
N/A-61.9%$13.70M$6.54MN/A197
QCLS
Mymd Pharmaceuticals
0.2292 of 5 stars
$0.79
-7.2%
N/AN/A$6.47MN/AN/A2

Related Companies and Tools


This page (NASDAQ:AIMD) was last updated on 10/6/2026 by MarketBeat.com Staff.
From Our Partners